HUP9900375A2 - Transzdermális mátrixrendszer, alkalmazása és előállítását szolgáló eljárás - Google Patents

Transzdermális mátrixrendszer, alkalmazása és előállítását szolgáló eljárás

Info

Publication number
HUP9900375A2
HUP9900375A2 HU9900375A HUP9900375A HUP9900375A2 HU P9900375 A2 HUP9900375 A2 HU P9900375A2 HU 9900375 A HU9900375 A HU 9900375A HU P9900375 A HUP9900375 A HU P9900375A HU P9900375 A2 HUP9900375 A2 HU P9900375A2
Authority
HU
Hungary
Prior art keywords
weight
parts
matrix system
transdermal matrix
producing
Prior art date
Application number
HU9900375A
Other languages
English (en)
Inventor
Bruno Bevan
Marie-Christine Math
Eric Teillaud
Original Assignee
Laboratoires D'hygiene Et De Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires D'hygiene Et De Dietetique filed Critical Laboratoires D'hygiene Et De Dietetique
Publication of HUP9900375A2 publication Critical patent/HUP9900375A2/hu
Publication of HUP9900375A3 publication Critical patent/HUP9900375A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Telephonic Communication Services (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány egy őlyan új hőrmőnők perkűtán bevitelére alkalmastranszdermális mátrixrendszerre vőnatkőzik, amely egy hőrdőzót és egytapadó mátrixőt tartalmaz. A mátrix összetétele a következő: a) 39-61tömegrész etilén/vinil-acetát kőpőlimer; b) 12-17 tömegrész 2-őktil-dődecil-mirisztát, c) 5-17 tömegrész dietil-ftalát; d) 10-16 tömegrészN-alkil-2-pirrőlidőn, amelyben az alkilcsőpőrt 4-15 szénatőmős; és e)1-12 tömegrész legalább egy hőrmőn, melyet ösztrőgén vagy prőgesztinhőrmőnkőmpőnensők közül választanak. A találmány tárgyát képezi afenti transzdermális mátrixrendszer előállítási eljárása ésgyógyászati alkalmazása is. ŕ
HU9900375A 1995-09-27 1996-09-25 Transdermal matrix system, its use and process for producing the same HUP9900375A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511326A FR2739032B1 (fr) 1995-09-27 1995-09-27 Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique

Publications (2)

Publication Number Publication Date
HUP9900375A2 true HUP9900375A2 (hu) 1999-06-28
HUP9900375A3 HUP9900375A3 (en) 1999-11-29

Family

ID=9482961

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900375A HUP9900375A3 (en) 1995-09-27 1996-09-25 Transdermal matrix system, its use and process for producing the same

Country Status (25)

Country Link
US (1) US6013276A (hu)
EP (1) EP0852492B1 (hu)
JP (1) JPH11514988A (hu)
KR (1) KR19990063732A (hu)
CN (1) CN1083259C (hu)
AT (1) ATE209031T1 (hu)
AU (1) AU702542B2 (hu)
BG (1) BG102322A (hu)
BR (1) BR9610665A (hu)
CA (1) CA2233162A1 (hu)
CZ (1) CZ95398A3 (hu)
DE (1) DE69617252T2 (hu)
DK (1) DK0852492T3 (hu)
EE (1) EE9800082A (hu)
ES (1) ES2170266T3 (hu)
FR (1) FR2739032B1 (hu)
HU (1) HUP9900375A3 (hu)
IL (1) IL123594A0 (hu)
NO (1) NO981252D0 (hu)
NZ (1) NZ319181A (hu)
PL (1) PL325644A1 (hu)
PT (1) PT852492E (hu)
SK (1) SK282613B6 (hu)
TR (1) TR199800563T1 (hu)
WO (1) WO1997011687A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049628C2 (de) * 1980-12-31 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5286490A (en) * 1990-05-04 1994-02-15 Colgate-Palmolive Company Transdermal fluoride medication
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
AU702542B2 (en) 1999-02-25
DE69617252T2 (de) 2002-07-25
CA2233162A1 (en) 1997-04-03
MX9802327A (es) 1998-08-30
PL325644A1 (en) 1998-08-03
AU7134996A (en) 1997-04-17
NO981252L (no) 1998-03-19
ES2170266T3 (es) 2002-08-01
CN1083259C (zh) 2002-04-24
IL123594A0 (en) 1998-10-30
NZ319181A (en) 1998-10-28
DE69617252D1 (de) 2002-01-03
EP0852492B1 (fr) 2001-11-21
WO1997011687A1 (fr) 1997-04-03
BR9610665A (pt) 1999-07-13
FR2739032A1 (fr) 1997-03-28
EE9800082A (et) 1998-10-15
BG102322A (en) 1998-10-30
SK40698A3 (en) 1998-09-09
CN1197390A (zh) 1998-10-28
KR19990063732A (ko) 1999-07-26
ATE209031T1 (de) 2001-12-15
JPH11514988A (ja) 1999-12-21
NO981252D0 (no) 1998-03-19
SK282613B6 (sk) 2002-10-08
HUP9900375A3 (en) 1999-11-29
PT852492E (pt) 2002-05-31
CZ95398A3 (cs) 1998-07-15
US6013276A (en) 2000-01-11
FR2739032B1 (fr) 1997-11-21
DK0852492T3 (da) 2002-05-13
TR199800563T1 (xx) 1998-06-22
EP0852492A1 (fr) 1998-07-15

Similar Documents

Publication Publication Date Title
HUP9900375A2 (hu) Transzdermális mátrixrendszer, alkalmazása és előállítását szolgáló eljárás
NO981315L (no) Transdermalt matrikssystem
HUP9904630A2 (hu) Új hidrazidvegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
ES483629A1 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
HUP9900949A2 (hu) Triazolilcsoportot tartalmazó foszfátok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
GB1515284A (en) Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
CA2060710A1 (en) Process for preparing 1,3-dioxols
HUP9702293A2 (hu) 4-Tiazolidinon-, rodanin- és 1,3-oxatiolán-5-on-származékok alkalmazása sclerosis multiplex kezelésére alkalmas gyógyszerkészítmények előállítására
ATE45937T1 (de) Mit radioaktivhalogen markierte verbindungen, insbesondere estradiolderivate, ihre herstellung und die erhaltenen zwischenprodukte.
Ponsold et al. Steroids XLI. preparation of 9α, 11ζ‐tritiated estrone‐3‐methyl ether and following syntheses of 17α‐CH2X‐derivatives of estradiol
Jones et al. Direct intermolecular transfer of dihydrogen between two transition metal complexes
HUP9801846A2 (hu) 17-(Difluor-metilén)-ösztratriének, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
Knox et al. The Reactions of Steroidal Alcohols with 2-chloro-1, 1, 2-trifluorotriethylamine
JPS55110171A (en) Adhesive composition
Harnik Studies in syntheses of steroid metabolites. Part IV
RU94023597A (ru) Способ получения поликристаллического алмаза заданной формы
HUP9802942A2 (hu) Eljárás sztreptograminok előállítására
Hübner et al. The synthetic approach to STS 557-structure activity relationships in 17α-CH2X-substituted 19-nortestosterone derivatives
US3743636A (en) Trialkylsilyloximo steroids
IE34171L (en) 17ó-penta - 1', 3' - diynyl steroids
JPS5649370A (en) Preparation of 1,2,4-triazole derivative
Liu-Gonzalez et al. 2-[(Z)-2-(p-Anisidino)-3, 3, 3-trifluoropropenyl]-4, 4-dimethyl-2-oxazoline
GB1165174A (en) 3-Substituted Methylene-Steroids and Process for their Manufacture
Street D77C F
Olijnyk X-ray diffraction studies of N2 up to 43. 9 Gpa